This inventor holds 4 USPTO granted patents. Top assignees: University of Iowa Research Foundation, British Technology Group Limited, University Patents, Inc.. Active years: 1979-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 1979-1993
Title: The Innovations of John P Long
Introduction
John P Long is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of pharmacology, particularly with his innovative compounds that serve as potential therapeutic agents. With a total of 4 patents, Long's work has implications for treating various medical conditions.
Latest Patents
One of Long's latest patents is for S-11-hydroxy-10-methylaporphine and its biologically active salt forms. These compounds act as 5-HT.sub.1A inhibitors, which can be utilized as antidotes for the effects of cocaine and as appetite suppressants. The chemical formula for S-11 Hydroxy-10-Methylaporphine is represented as: ##STR1##. Another significant patent involves a method of increasing renal blood flow using dopamine derivatives. Certain N,N-dialkyl substituted derivatives of dopamine (DA) have been shown to enhance renal blood flow without impacting cardiac contractility. Notably effective derivatives include N,N-di-n-propyl DA and N-n-propyl-N-n-butyl DA, among others.
Career Highlights
Throughout his career, John P Long has been associated with reputable institutions such as the University of Iowa Research Foundation and University Patents, Inc. His work has not only advanced scientific understanding but has also paved the way for practical applications in medicine.
Collaborations
Long has collaborated with esteemed colleagues, including Joseph G Cannon and John N Diana. These partnerships have contributed to the development and refinement of his innovative ideas.
Conclusion
John P Long's contributions to the field of pharmacology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of therapeutic agents that address critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile